|
|
|
Volumn 23, Issue 6 SUPPL. 13, 1996, Pages 51-60
|
|
A pharmacoeconomic evaluation of cisplatin in combination with either etoposide or etoposide phosphate in small cell lung cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
ETOPOFOS;
ETOPOSIDE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
COST MINIMIZATION ANALYSIS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
ECONOMIC ASPECT;
HUMAN;
LUNG SMALL CELL CANCER;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SMALL CELL;
CISPLATIN;
COSTS AND COST ANALYSIS;
ECONOMICS, PHARMACEUTICAL;
ETOPOSIDE;
HUMANS;
LUNG NEOPLASMS;
MODELS, ECONOMIC;
ORGANOPHOSPHORUS COMPOUNDS;
|
|
EID: 0030465848
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (29)
|
